Haemonetics Corp. (HAE)
101.92
-1.16
(-1.12%)
USD |
NYSE |
Sep 01, 16:00
101.01
-0.90
(-0.89%)
After-Hours: 17:19
Haemonetics Cash from Operations (TTM) : 328.15M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 328.15M |
| March 31, 2026 | 293.22M |
| December 31, 2025 | 338.84M |
| September 30, 2025 | 289.04M |
| June 30, 2025 | 226.54M |
| March 31, 2025 | 181.72M |
| December 31, 2024 | 129.25M |
| September 30, 2024 | 84.94M |
| June 30, 2024 | 135.24M |
| March 31, 2024 | 181.75M |
| December 31, 2023 | 196.16M |
| September 30, 2023 | 261.12M |
| June 30, 2023 | 249.03M |
| March 31, 2023 | 271.94M |
| December 31, 2022 | 261.50M |
| September 30, 2022 | 259.52M |
| June 30, 2022 | 215.94M |
| March 31, 2022 | 172.26M |
| December 31, 2021 | 105.76M |
| September 30, 2021 | 109.62M |
| June 30, 2021 | 95.31M |
| March 31, 2021 | 108.80M |
| December 31, 2020 | 153.66M |
| September 30, 2020 | 166.66M |
| June 30, 2020 | 167.40M |
| Date | Value |
|---|---|
| March 31, 2020 | 158.22M |
| December 31, 2019 | 132.45M |
| September 30, 2019 | 111.33M |
| June 30, 2019 | 138.79M |
| March 31, 2019 | 159.28M |
| December 31, 2018 | 196.27M |
| September 30, 2018 | 203.50M |
| June 30, 2018 | 205.05M |
| March 31, 2018 | 220.35M |
| December 31, 2017 | 197.30M |
| September 30, 2017 | 187.11M |
| June 30, 2017 | 167.47M |
| March 31, 2017 | 159.74M |
| December 31, 2016 | 178.41M |
| September 30, 2016 | 155.06M |
| June 30, 2016 | 143.31M |
| March 31, 2016 | 121.86M |
| December 31, 2015 | 123.92M |
| September 30, 2015 | 118.96M |
| June 30, 2015 | 122.69M |
| March 31, 2015 | 127.18M |
| December 31, 2014 | 123.34M |
| September 30, 2014 | 141.74M |
| June 30, 2014 | 139.86M |
| March 31, 2014 | 139.52M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Globus Medical, Inc. | 910.39M |
| Abbott Laboratories | 9.905B |
| AngioDynamics, Inc. | 3.089M |
| Alphatec Holdings, Inc. | 56.52M |
| AtriCure, Inc. | 64.94M |